Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Reale, Antonia ^a   Melaccio, Assunta ^a   Lamanuzzi, Aurelia ^a   Saltarella, Ilaria ^a   Dammacco, Franco ^a   Vacca, Angelo ^a   Ria, Roberto ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANGIOGENESIS; CAPILLARY DENSITY; CELL HOMING; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; IN VITRO STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 84953923766     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/7954580     Document Type: Review

References (101)

1. S. Patan, "Vasculogenesis and angiogenesis, " Cancer Treatment and Research, vol. 117, pp. 3-32, 2004.
2. D. S. Charnock-Jones, P. Kaufmann, and T. M. Mayhew, "Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation, " Placenta, vol. 25, no. 2-3, pp. 103-113, 2004.
3. T. Asahara, T. Murohara, A. Sullivan et al. , "Isolation of putative progenitor endothelial cells for angiogenesis, " Science, vol. 275, no. 5302, pp. 964-967, 1997.
4. S. Balaji, A. King, T. M. Crombleholme, and S. G. Keswani, "The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing, " Advances in Wound Care, vol. 2, no. 6, pp. 283-295, 2013.
5. B. Assmus, J. Honold, V. Schachinger et al. , "Transcoronary transplantation of progenitor cells after myocardial infarction, " The New England Journal of Medicine, vol. 355, no. 12, pp. 1222-1232, 2006.
6. J. Li, Y.-P. Zhang, and R. S. Kirsner, "Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix, " Microscopy Research and Technique, vol. 60, no. 1, pp. 107-114, 2003.
7. T. Matsumoto, A. Kawamoto, R. Kuroda et al. , "Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing, " American Journal of Pathology, vol. 169, no. 4, pp. 1440-1457, 2006.
8. Y. Shaked, F. Bertolini, S. Man et al. , "Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; implications for cellular surrogate marker analysis of antiangiogenesis, " Cancer Cell, vol. 7, no. 1, pp. 101-111, 2005.
9. R. Ria, A. Reale, A. De Luisi, A. Ferrucci, M. Moschetta, and A. Vacca, "Bonemarrow angiogenesis and progression inmultiple myeloma, " American Journal of Blood Research, vol. 1, no. 1, p. 7689, 2011.
10. J. G. Roncalli, J. Tongers, M.-A. Renault, and D. W. Losordo, "Endothelial progenitor cells in regenerativemedicine and cancer: a decade of research, " Trends in Biotechnology, vol. 26, no. 5, pp. 276-283, 2008.
11. T. Asahara, H. Masuda, T. Takahashi et al. , "Bonemarroworigin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, " Circulation Research, vol. 85, no. 3, pp. 221-228, 1999.
12. A. Grochot-Przeczek, M. Kozakowska, J. Dulak, and A. Jozkowicz, "Endothelial cell origin, differentiation, heterogeneity and function, " in Angiogenesis and Vascularisation, pp. 3-26, Springer, Vienna, Austria, 2013.
13. S.-I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, and H. Kodama, "Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages, " Development, vol. 125, no. 9, pp. 1747-1757, 1998.
14. T. L. Huber, V. Kouskoff, H. J. Fehling, J. Palis, and G. Keller, "Haemangioblast commitment is initiated in the primitive streak of themouse embryo, " Nature, vol. 432, no. 7017, pp. 625-630, 2004.
15. K. M. Vogeli, S.-W. Jin, G. R. Martin, and D. Y. R. Stainier, "A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula, " Nature, vol. 443, no. 7109, pp. 337-339, 2006.
16. C. Furuta, H. Ema, S.-I. Takayanagi et al. , "Discordant developmental waves of angioblasts and hemangioblasts in the early gastrulating mouse embryo, " Development, vol. 133, no. 14, pp. 2771-2779, 2006.
17. M. Hristov, W. Erl, and P. C. Weber, "Endothelial progenitor cells: mobilization, differentiation, and homing, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 7, pp. 1185-1189, 2003.
18. N. Quirici, D. Soligo, L. Caneva, F. Servida, P. Bossolasco, and G. L. Deliliers, "Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells, " British Journal of Haematology, vol. 115, no. 1, pp. 186-194, 2001.
19. S. Kaushal, G. E. Amiel, K. J. Guleserian et al. , "Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo, " Nature Medicine, vol. 7, no. 9, pp. 1035-1040, 2001.
20. A. Kawamoto, H. Iwasaki, K. Kusano et al. , "CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells, " Circulation, vol. 114, no. 20, pp. 2163-2169, 2006.
21. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al. , "Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, " Nature Medicine, vol. 7, no. 4, pp. 430-436, 2001.
22. H. Masuda, C. Alev, H. Akimaru et al. , "Methodological development of a clonogenic assay to determine endothelial progenitor cell potential, " Circulation Research, vol. 109, no. 1, pp. 20-37, 2011.
23. J. Case, L. E. Mead, W. K. Bessler et al. , "Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors, " Experimental Hematology, vol. 35, no. 7, pp. 1109-1118, 2007.
24. P. Madeddu, C. Emanueli, E. Pelosi et al. , "Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs, " The FASEB Journal, vol. 18, no. 14, pp. 1737-1739, 2004.
25. E. B. Friedrich, K. Walenta, J. Scharlau, G. Nickenig, and N. Werner, "CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities, " Circulation Research, vol. 98, no. 3, pp. e20-e25, 2006.
26. M. Peichev, A. J. Naiyer, D. Pereira et al. , "Expression ofVEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors, " Blood, vol. 95, no. 3, pp. 952-958, 2000.
27. R. Handgretinger, P. R. Gordon, T. Leimig et al. , "Biology and plasticity of CD133+ hematopoietic stem cells, " Annals of the New York Academy of Sciences, vol. 996, pp. 141-151, 2003.
28. P. P. Young, D. E. Vaughan, and A. K. Hatzopoulos, "Biologic properties of endothelial progenitor cells and their potential for cell therapy, " Progress in Cardiovascular Diseases, vol. 49, no. 6, Article ID 421429, pp. 421-429, 2007.
29. G. P. Fadini, D. Losordo, and S. Dimmeler, "Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, " Circulation Research, vol. 110, no. 4, pp. 624-637, 2012.
30. B. Dome, J. Dobos, J. Tovari et al. , "Circulating bone marrowderived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease, " Cytometry Part A, vol. 73, no. 3, pp. 186-193, 2008.
31. J. Hur, H.-M. Yang, C.-H. Yoon et al. , "Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies, " Circulation, vol. 116, no. 15, pp. 1671-1682, 2007.
32. P. S. Lee and K. K. Poh, "Endothelial progenitor cells in cardiovascular diseases, " World Journal of Stem Cells, vol. 6, no. 3, pp. 355-366, 2014.
33. D. N. Prater, J. Case, D. A. Ingram, and M. C. Yoder, "Working hypothesis to redefine endothelial progenitor cells, " Leukemia, vol. 21, no. 6, pp. 1141-1149, 2007.
34. G. Piaggio, V. Rosti, M. Corselli et al. , "Endothelial colonyforming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker, " Blood, vol. 114, no. 14, pp. 3127-3130, 2009.
35. P. C. Raemer, S. Haemmerling, T. Giese et al. , "Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity, " Transplantation, vol. 87, no. 3, pp. 340-349, 2009.
36. M. Prokopi, G. Pula, U. Mayr et al. , "Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures, " Blood, vol. 114, no. 3, pp. 723-732, 2009.
37. J. D. Pearson, "Endothelial progenitor cells-hype or hope?" Journal of Thrombosis and Haemostasis, vol. 7, no. 2, pp. 255-262, 2009.
38. J. D. Pearson, "Endothelial progenitor cells-an evolving story, " Microvascular Research, vol. 79, no. 3, pp. 162-168, 2010.
39. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, "Vascular endothelial growth factor (VEGF) and its receptors, " The FASEB Journal, vol. 13, no. 1, pp. 9-22, 1999.
40. K. L. Marcelo, L. C. Goldie, and K. K. Hirschi, "Regulation of endothelial cell differentiation and specification, " Circulation Research, vol. 112, no. 9, pp. 1272-1287, 2003.
41. F. Shalaby, J. Rossant, T. P. Yamaguchi et al. , "Failure of bloodisland formation and vasculogenesis in Flk-1-deficient mice, " Nature, vol. 376, no. 6535, pp. 62-66, 1995.
42. S. Patel-Hett and P. A. DAmore, "Signal transduction in vasculogenesis and developmental angiogenesis, " International Journal of Developmental Biology, vol. 55, no. 4-5, pp. 353-369, 2011.
43. V. W. Wong and J. D. Crawford, "Vasculogenic cytokines in wound healing, " BioMed Research International , vol. 2013, Article ID 190486, 11 pages, 2013.
44. M. C. Dickson, J. S. Martin, F. M. Cousins, A. B. Kulkarni, S. Karlsson, and R. J. Akhurst, "Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice, " Development, vol. 121, no. 6, pp. 1845-1854, 1995.
45. J. J. Letterio, A. G. Geiser, A. B. Kulkarni, N. S. Roche, M. B. Sporn, and A. B. Roberts, "Maternal rescue of transforming growth factor-β1 null mice, " Science, vol. 264, no. 5167, pp. 1936-1938, 1994.
46. K. E. McGrath, A. D. Koniski, K. M. Maltby, J. K. McGann, and J. Palis, "Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4, "Developmental Biology, vol. 213, no. 2, pp. 442-456, 1999.
47. D. Y. Li, L. K. Sorensen, B. S. Brooke et al. , "Defective angiogenesis in mice lacking endoglin, " Science, vol. 284, no. 5419, pp. 1534-1537, 1999.
48. Z. Liu, F. Lebrin, J. A. Maring et al. , "Endoglin is dispensable for vasculogenesis, but required for vascular endothelial growth factorinduced angiogenesis, " PLoS ONE, vol. 9, no. 1, Article ID e86273, 2014.
49. K. Podar and K. C. Anderson, "The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications, " Blood, vol. 105, no. 4, pp. 1383-1395, 2005.
50. L. A. Milner andA. Bigas, "Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation, " Blood, vol. 93, no. 8, pp. 2431-2448, 1999.
51. A. Fischer, N. Schumacher, M. Maier, M. Sendtner, and M. Gessler, "The notch target genes Hey1 and Hey2 are required for embryonic vascular development, " Genes and Development, vol. 18, no. 8, pp. 901-911, 2004.
52. S.-M. Kwon, C. Alev, and T. Asahara, "The role of notch signaling in endothelial progenitor cell biology, " Trends in Cardiovascular Medicine, vol. 19, no. 5, pp. 170-173, 2009.
53. Z. Liu, F. Fan, A. Wang, S. Zheng, and Y. Lu, "Dll4-Notch signaling in regulation of tumor angiogenesis, " Journal of Cancer Research and Clinical Oncology, vol. 140, no. 4, pp. 525-536, 2014.
54. J. Jiang and C.-C. Hui, "Hedgehog signaling in development and cancer, " Developmental Cell, vol. 15, no. 6, pp. 801-812, 2008.
55. S. A. Vokes, T. A. Yatskievych, R. L. Heimark et al. , "Hedgehog signaling is essential for endothelial tube formation during vasculogenesis, " Development, vol. 131, no. 17, pp. 4371-4380, 2004.
56. T. Nagase, M. Nagase, M. Machida, and T. Fujita, "Hedgehog signalling in vascular development, " Angiogenesis, vol. 11, no. 1, pp. 71-77, 2008.
57. W. Chen, T. Tang, J. Eastham-Anderson et al. , "Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 23, pp. 9589-9594, 2011.
58. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher, "Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, " Nature, vol. 399, no. 6736, pp. 601-605, 1999.
59. B. Heissig, K. Hattori, S. Dias et al. , "Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand, " Cell, vol. 109, no. 5, pp. 625-637, 2002.
60. G. C. Schatteman, M. Dunnwald, and C. Jiao, "Biology of bone marrow-derived endothelial cell precursors, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 1, pp. H1-H18, 2007.
61. G. Furstenberger, R. Von Moos, R. Lucas et al. , "Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer, " British Journal of Cancer, vol. 94, no. 4, pp. 524-531, 2006.
62. J. W. Y. Ho, R. W. C. Pang, C. Lau et al. , "Significance of circulating endothelial progenitor cells in hepatocellular carcinoma, " Hepatology, vol. 44, no. 4, pp. 836-843, 2006.
63. L. M. Scott, G. V. Priestley, and T. Papayannopoulou, "Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing, " Molecular and Cellular Biology, vol. 23, no. 24, pp. 9349-9360, 2003.
64. C. Urbich and S. Dimmeler, "Endothelial progenitor cells: characterization and role in vascular biology, " Circulation Research, vol. 95, no. 4, pp. 343-353, 2004.
65. E. Chavakis, A. Aicher, C. Heeschen et al. , "Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells, " The Journal of Experimental Medicine, vol. 201, no. 1, pp. 63-72, 2005.
66. C. Bouvard, B. Gafsou, B. Dizier et al. , "α6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1569-1575, 2010.
67. G. Qin, M. Ii, M. Silver et al. , "Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization, " Journal of Experimental Medicine, vol. 203, no. 1, pp. 153-163, 2006.
68. F. Caiado, C. Real, T. Carvalho, and S. Dias, "Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential, " PLoS ONE, vol. 3, no. 11, Article ID e3752, 2008.
69. T. Takahashi, C. Kalka, H. Masuda et al. , "Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, " Nature Medicine, vol. 5, no. 4, pp. 434-438, 1999.
70. F. H. Bahlmann, K. de Groot, J.-M. Spandau et al. , "Erythropoietin regulates endothelial progenitor cells, " Blood, vol. 103, no. 3, pp. 921-926, 2004.
71. M. Moschetta, Y. Mishima, I. Sahin et al. , "Role of endothelial progenitor cells in cancer progression, " Biochimica et Biophysica Acta, vol. 1846, no. 1, pp. 26-39, 2014.
72. A. R. Perez-Atayde, S. E. Sallan, U. Tedrow, S. Connors, E. Allred, and J. Folkman, "Spectrumof tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia, " American Journal of Pathology, vol. 150, no. 3, pp. 815-821, 1997.
73. S. Faderl, K.-A. Do, M. M. Johnson et al. , "Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia, " Blood, vol. 106, no. 13, pp. 4303-4307, 2005.
74. J. W. Hussong, G. M. Rodgers, and P. J. Shami, "Evidence of increased angiogenesis in patients with acute myeloid leukemia, " Blood, vol. 95, no. 1, pp. 309-313, 2000.
75. I. Kuzu, M. Beksac, M. Arat, H. Celebi, A. H. Elhan, and S. Erekul, "Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival, " Leukemia and Lymphoma, vol. 45, no. 6, pp. 1185-1190, 2004.
76. W. Fiedler, U. Graeven, S. Ergun et al. , "Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia, " Blood, vol. 89, no. 6, pp. 1870-1875, 1997.
77. A. F. List, "Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies, " The Oncologist, vol. 6, supplement 5, pp. 24-31, 2001.
78. A. Trujillo, C. McGee, and C. R. Cogle, "Angiogenesis in acute myeloid leukemia and opportunities for novel therapies, " Journal of Oncology, vol. 2012, Article ID 128608, 9 pages, 2012.
79. G. J. Madlambayan, A. M. Meacham, K. Hosaka et al. , "Leukemia regression by vascular disruption and antiangiogenic therapy, " Blood, vol. 116, no. 9, pp. 1539-1547, 2010.
80. H.-A. Hou, W.-C. Chou, L.-I. Lin et al. , "Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acutemyeloid leukemia, " Leukemia Research, vol. 32, no. 6, pp. 904-912, 2008.
81. S. Yetgin, I. Yenicesu, M. Cetin, and M. Tuncer, "Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia, " Leukemia and Lymphoma, vol. 42, no. 1-2, pp. 83-88, 2001.
82. A. Bikfalvi and Z. C. Man, "Angiogenic factors are hematopoietic growth factors and vice versa, " Leukemia, vol. 8, no. 3, pp. 523-529, 1994.
83. A. Aguayo, H. Kantarjian, T. Manshouri et al. , "Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes, " Blood, vol. 96, no. 6, pp. 2240-2245, 2000.
84. M. A. Pule, C. Gullmann, D. Dennis, C. McMahon, M. Jeffers, and O. P. Smith, "Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance, " British Journal of Haematology, vol. 118, no. 4, pp. 991-998, 2002.
85. G. M. Rigolin, R. Maffei, L. Rizzotto et al. , "Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance, " Cancer, vol. 116, no. 8, pp. 1926-1937, 2010.
86. L. G. Lundberg, R. Lerner, P. Sundelin, R. Rogers, J. Folkman, and J. Palmblad, "Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity, " The American Journal of Pathology, vol. 157, no. 1, pp. 15-19, 2000.
87. D. Ribatti, B. Nico, G. Ranieri, G. Specchia, and A. Vacca, "The role of angiogenesis in human non-Hodgkin lymphomas, " Neoplasia, vol. 15, no. 3, pp. 231-238, 2013.
88. C. Igreja, M. Courinha, A. S. Cachaco et al. , "Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients, " Haematologica, vol. 92, no. 4, pp. 469-477, 2007.
89. V. Klimek, "Myelodysplastic syndromes (MDS), " Best Practice & Research Clinical Haematology, vol. 28, no. 1, p. 12, 2015.
90. P. Korkolopoulou, E. Apostolidou, P. M. Pavlopoulos et al. , "Prognostic evaluation of the microvascular network in myelodysplastic syndromes, " Leukemia, vol. 15, no. 9, pp. 1369-1376, 2001.
91. M. G. Della Porta, L. Malcovati, G. M. Rigolin et al. , "Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes, " Leukemia, vol. 22, no. 3, pp. 530-537, 2008.
92. B. A. Peters, L. A. Diaz Jr. , K. Polyaket al. , "Contributionof bone marrow-derived endothelial cells to human tumor vasculature, " Nature Medicine, vol. 11, no. 3, pp. 261-262, 2005.
93. A. Vacca, R. Ria, D. Ribatti et al. , "A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth inmultiplemyeloma, " Haematologica, vol. 88, no. 2, pp. 176-185, 2003.
94. A. Vacca, D. Ribatti, L. Roncali et al. , "Bone marrow angiogenesis and progression in multiple myeloma, " British Journal of Haematology, vol. 87, no. 3, pp. 503-508, 1994.
95. A. Bhaskar, R. Gupta, L. Kumar et al. , "Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma, " Leukemia & Lymphoma, vol. 53, no. 4, pp. 635-640, 2012.
96. H. Zhang, V. Vakil, M. Braunstein et al. , "Circulating endothelial progenitor cells in multiple myeloma: implications and significance, " Blood, vol. 105, no. 8, pp. 3286-3294, 2005.
97. RA. Mesa, C. A. Hanson, S. V. Rajkumar, G. Schroeder, and A. Tefferi, "Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia, " Blood, vol. 96, no. 10, pp. 3374-3380, 2000.
98. D. Sukmawati and R. Tanaka, "Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine, "American Journal of Translational Research, vol. 7, no. 3, pp. 411-421, 2015.
99. M. Ammendola, C. Leporini, M. Luposella et al. , "Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy, " Current StemCell Research&Therapy, vol. 10, no. 2, pp. 181-187, 2015.
100. D. J. Nolan, A. Ciarrocchi, A. S. Mellick et al. , "Bone marrowderived endothelial progenitor cells are a major determinant of nascent tumor neovascularization, " Genes & Development, vol. 21, no. 12, pp. 1546-1558, 2007.
101. D. Gao, D. J. Nolan, A. S. Mellick, K. Bambino, K. McDonnell, and V. Mittal, "Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis, " Science, vol. 319, no. 5860, pp. 195-198, 2008.